Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 20

Sort by

Sort Order Select

Journal Articles

Frequency, Clinical Characteristics and Outcome of Adult Patients with Acute Lymphoblastic Leukemia (ALL) and COVID-19 in Spain: Results of a Survey from Pethema and Geth Groups

Blood (2020) 136 (Supplement 1): 19.

https://doi.org/10.1182/blood-2020-134296

Published: 2020

Journal Articles

Identification of Immunological Parameters Related to Relapse in Patients with Chronic Myeloid Leukemia on Treatment-Free Remission

Valentín Garcia-Gutiérrez, MD PhD, Lorena Vigon, Laura Checa, Alejandro Luna, MD, Miguel Piris-Villaespesa, MD, Sara Rodriguez-Mora, Guiomar Bautista, Juan Luis Steegmann, Prof., MD, Vicente Planelles, Jose Alcamí, Maria Rosa López-Huertas, Maria Teresa Coiras

Blood (2019) 134 (Supplement_1): 191.

https://doi.org/10.1182/blood-2019-130017

Published: 2019

Journal Articles

Leukemogenesis in Seven Donor Cell Derived Myeloid Neoplasms Patients. Whole Exome Sequencing Reveals Clonal Dynamics

Julia Suárez González, Juan Carlos Triviño, Mi Kwon, Angela Figuera Alvarez, MD PhD, Guiomar Bautista, Jose Garcia-Marco, MD PhD, Antonio Balas, Jose Luis Vicario, Francisco José Ortuño, Raul Teruel Montoya, PhD, Jose María Álamo, Pascual Balsalobre, PhD, José Luís Díez Martín, MD, Carolina Martínez-Laperche, Ismael Buño, PhD

Blood (2018) 132 (Supplement 1): 2752.

https://doi.org/10.1182/blood-2018-99-118894

Published: 2018

Journal Articles

Real Life Long-Term Survival Analysis in Patients with Chronic Myeloid Leukemia Treated with Tkis in Spain

Luis Felipe Casado Montero, Valentin Garcia Gutierrez, MD, Pilar Giraldo, MD PhD, Manuel Perez-Encinas, Raquel de Paz, Joaquin Martinez-Lopez, Guiomar Bautista, Santiago Osorio, Maria Jose Requena, Luis Palomera, MD PhD, Maria Jesús Peñarrubia, Carmen Calle, Jose Angel Hernandez-Rivas, Nuria García-Ormeña, Juan Luis Steegmann, MD PhD

Blood (2016) 128 (22): 3074.

https://doi.org/10.1182/blood.V128.22.3074.3074

Published: 2016

Journal Articles

High Correlation Clinical Responses to 1 st Line Acute Myeloid Leukemia Treatment with an Ex Vivo Native Environment Precision Medicine Test

Pau Montesinos, MD, Joan Ballesteros, David Martínez-Cuadrón, Joaquín Martínez-López, Josefina Serrano, Jaime Perez de Oteyza, Pascual Fernández, Gabriela Rodriguez-Macías, Mª Belén Vidriales, Pilar Herrera, MD PhD, Mar Tormo, MD PhD, Juan Bergua, Raimundo García, MD, Susana Vives, Mª Ángeles Fernández, Esperanza Lavilla, MD, Santiago Jimenez, Jose Antonio Pérez-Simón, Adriana Simiele, Ataulfo González, Bernardo J. González, Carmen Burgaleta, Juan Antonio López, Concepción Bethancourt, Guiomar Bautista, Arancha Alonso, Mercedes Colorado, Jordi Sierra, Begoña Navas, José Angel Hernández-Rivas, Juan Antonio Vera, Mª Lourdes Amador, Raúl Cordoba, MD, Adolfo de la Fuente, Fernando Ramos, MD PhD MPH, Carlos Javier Cerveró, Consolación Rayón, Olga Salamero, Edelmira Martí, Aurelio López, Teresa Olavé, Marta Gaspar, Julian Gorrochategui, José Luis Rojas, Cristina Gomez, Pilar Hernández, Alicia Robles, Ignacio Ortega, Jesús Villoria, Federico Moscardó, Iñaki Troconiz, Miguel A. Sanz, MD PhD

Blood (2015) 126 (23): 4837.

https://doi.org/10.1182/blood.V126.23.4837.4837

Published: 2015

Journal Articles

Safety and Efficacy of Bosutinib in Fourth Line Therapy of Chronic Myeloid Leukemia Patients

Valentín García-Gutiérrez, Dragana Milojkovic, María Luisa Martín Mateos, Simone Claudiani, Concepcion Boque, PhD, Luis Felipe Casado, Gloria González, Antonio Jiménez, Alejandra Martinez Trillos, Isabel Mata Vázquez, Ángel Ramírez Payer, Alberto Álvarez Larran, Elena Amutio Díez, Abelardo Bárez García, MD, Guiomar Bautista Carrascosa, Sabela Bobillo Varela, Beatriz Cuevas Ruiz, Mª Ángeles Fernández Fernández, María del Carmen García Garay, Pilar Giraldo, MD PhD, Jose María Guinea de Castro, Natalia De Las Heras Rodríguez, MD, Nuria Hernanz Soler, Ana Iglesias Pérez, José Luis López Lorenzo, Josep Maria Martí Tutusaus, MD PhD, Rolando Omar Vallansot, Fernando Ortega Rivas, Jose Manuel Puerta, Maria Jose Ramírez Sánchez, Esperanza Romero Picos, Mario Andrés Romo Collada, Ana Rosell Mas, Silvana Saavedra Gerosa, Ana Sebrango Sadia, José Tallón Pérez, Sandra Valencia, Juan Luis Steegmann, MD

Blood (2015) 126 (23): 2786.

https://doi.org/10.1182/blood.V126.23.2786.2786

Published: 2015

Journal Articles

Bosutinib Apears to be Safe, with Low Cross Intolerance, in Patients Treated in 4th Line. Results of the Spanish Compassionate Use Program

Blood (2014) 124 (21): 5523.

https://doi.org/10.1182/blood.V124.21.5523.5523

Published: 2014

Journal Articles

Paroxysmal Nocturnal Hemoglobinuria and Thrombosis Before and After Eculizumab

Cristina Muñoz-Linares, MD, Miguel Pastrana, MD, Emilio Ojeda, MD, PhD, Rafael Fores, MD, Martin Cabero, MD, Daniel Morillo, MD, Guiomar Bautista, MD, Belen Navarro, MD, Isabel Krsnik, MD, PhD, Santiago Gil, MD, PhD, Carmen Regidor, MD, PhD, Almudena de LaIglesia, MD, Jose Luis Bueno, MD, Jose A Garcia-Marco, MD, PhD, Jose Rafael Cabrera, MD, PhD

Blood (2013) 122 (21): 1242.

https://doi.org/10.1182/blood.V122.21.1242.1242

Published: 2013

Journal Articles

Paroxysmal Nocturnal Hemoglobinuria and Cancer: High Incidence Of Cancer In a Large Series Of PNH Patients In a Single Center

Cristina Muñoz-Linares, MD, Emilio Ojeda, MD, PhD, Rafael Fores, MD, Martin Cabero, MD, Daniel Morillo, MD, Guiomar Bautista, MD, Belen Navarro, MD, Isabel Krsnik, MD, PhD, Santiago Gil, MD, PhD, Almudena de LaIglesia, MD, Carmen Regidor, MD, PhD, Jose Luis Bueno, MD, Jose A Garcia-Marco, MD, PhD, Jose Rafael Cabrera, MD, PhD

Blood (2013) 122 (21): 4871.

https://doi.org/10.1182/blood.V122.21.4871.4871

Published: 2013

Journal Articles

Paroxysmal Nocturnal Hemoglobinuria and Magnetic Resonance Imaging

Miguel Pastrana, MD, Cristina Muñoz-Linares, MD, Emilio Ojeda, MD, PhD, Rafael Fores, MD, Beatriz Brea, MD, Martin Cabero, MD, Daniel Morillo, MD, Guiomar Bautista, MD, Belen Navarro, MD, Isabel Krsnik, MD, PhD, Almudena de LaIglesia, MD, Santiago Gil, MD, PhD, Carmen Regidor, MD, PhD, Jose Luis Bueno, MD, Jose A Garcia-Marco, MD, PhD, Jose Rafael Cabrera, MD, PhD

Blood (2013) 122 (21): 4873.

https://doi.org/10.1182/blood.V122.21.4873.4873

Published: 2013

Journal Articles

Outcomes of Chronic Myeloid Leukemia (CML) Patients Who Stopped Second Generation Tyrosine Kinase Inhibitors (2GTKIs) As Second Line Treatment. Results of the CML Spanish National Registry (RELMC)

J Valentin Garcia-Gutierrez, MD, PhD, Begoña Maestro, Luis Felipe Casado, MD, PhD, Manuel Perez-Encinas, Isabel Massague, Raquel de Paz, Santiago Osorio, Joaquin Martinez, MD, Guiomar Bautista, MD, Pilar Giraldo, Carmen Burgaleta, Maria Jesús Peñarrubia, Maria José Requena, Carmen Calle, Jose Ángel Hernández-Rivas, Pilar Cano, Juan Luis Steegmann, MD, PhD

Blood (2012) 120 (21): 3764.

https://doi.org/10.1182/blood.V120.21.3764.3764

Published: 2012

Journal Articles

Switching to a Second Generation TKI in Chronic Myeloid Leukemia Patients with Late Suboptimal Response with Imatinib Obtained Better Molecular Responses That the “Watch and Wait” Approach. an Experience of a Multicenter Registry in Patients Outside Clinical Trials

J Valentin Garcia-Gutierrez, MD, PhD, Begoña Maestro, Luis Felipe Casado, MD, PhD, Manuel Perez-Encinas, Isabel Massague, Raquel De Paz, MD, Santiago Osorio, Joaquin Martinez, MD, Guiomar Bautista, MD, Pilar Giraldo, Carmen Burgaleta, Maria Jesús Peñarrubia, Maria José Requena, Carmen Calle, Jose Angel Hernandez-rivas, MD, Pilar Cano, Juan Luis Steegmann, MD, PhD

Blood (2012) 120 (21): 3768.

https://doi.org/10.1182/blood.V120.21.3768.3768

Published: 2012

Journal Articles

A Good Adherence to ELN 09 Recommendations in Chronic Myeloid Leukemia (CML) Treatment with Imatinib, Is Associated with Better Outcomes in Patients Treated Outside Clinical Trials

Blood (2012) 120 (21): 3762.

https://doi.org/10.1182/blood.V120.21.3762.3762

Published: 2012

Journal Articles

Use of Romiplostim to Facilitate Platelet Engraftment in Allogeneic Hematopoietic Transplantation

Emilio Ojeda, MD, PhD, Jose A. Garcia-Marco, MD, PhD, Belen Navarro, MD, Almudena DelaIglesia, MD, Rafael Fores, MD, Guiomar Bautista, MD, Isabel Krsnik, MD, PhD, Amelia Sanchez-Guerrero, PhD, Isabel SanJuan, MD, Carmen Regidor, MD, Santiago Gil, MD, PhD, Rosa Gonzalo-Daganzo, Biol, PhD, Trinidad Martin-Donaire, MD, Ph, Rocio Sanchez, ND, Gracia Bravo, ND, Nuria Claros, MD, Martin Cabero, MD, Pilar Beltran, MD, Jose Rafael Cabrera, MD, PhD

Blood (2011) 118 (21): 1947.

https://doi.org/10.1182/blood.V118.21.1947.1947

Published: 2011

Journal Articles

Analysis of Procoagulants Phospholipids in Plasma of Paroxysmal Nocturnal Hemoglobinuria Patients,Processed in Differents Preanalytic Conditions

Blood (2011) 118 (21): 5258.

https://doi.org/10.1182/blood.V118.21.5258.5258

Published: 2011

Journal Articles

Survival and Response Outcomes to Different Treatment Schedules in CML Patients Starting Therapy with Imatinib. Results from the CML Spanish Registry (RELMC)

Luis Felipe Casado, Isabel Massague, Pilar Giraldo, PhD, Manuel Perez-Encinas, Raquel De Paz, MD, Joaquín Martínez-López, Guiomar Bautista, Santiago Osorio, Maria José Requena, Luis Palomera, Maria Jesús Peñarrubia, Carmen Calle, Begoña Maestro, Juan Luis Steegmann, MD, PhD

Blood (2010) 116 (21): 1237.

https://doi.org/10.1182/blood.V116.21.1237.1237

Published: 2010

Journal Articles

Use of Third Party Ancillary Cells for Enhancement of Full Donor Chimerism and Immunomodulation in Cord Blood Transplants.

Manuel N. Fernandez, Jose R. Cabrera, Carmen Regidor, Guiomar Bautista, Emilio Ojeda, Rafael Fores, Isabel Sanjuan, Elena Ruiz, Santiago Gil, Rosa Gonzalo, Isabel Millan, Isabel Krsnik, Belen Navarro, Jose A. Garcia-Marco

Blood (2007) 110 (11): 335.

https://doi.org/10.1182/blood.V110.11.335.335

Published: 2007

Journal Articles

Single Unit Cord Blood Transplant Supported by Third Party Highly Purified Mobilized Hematopoietic Stem Cells: Immune Reconstitution Studies.

Blood (2006) 108 (11): 311.

https://doi.org/10.1182/blood.V108.11.311.311

Published: 2006

Journal Articles

Post-Engraftment Infections in Adult Patients Transplanted with Single Cord Blood Units Supported by Co-Infusion of Mobilized Purified Hematopoietic Stem Cells from a Third Party Donor.

J. Rafael Cabrera, Isabel Krsnik, Rafael Fores, Elena Ruiz, Guiomar Bautista, Belen Navarro, Jorge Gayoso, Santiago Gil, Carmen Regidor, Isabel Sanjuan, Emilio Ojeda, Jose A. Garcia-Marco, Manuel N. Fernandez

Blood (2005) 106 (11): 3240.

https://doi.org/10.1182/blood.V106.11.3240.3240

Published: 2005

Journal Articles

Unrelated Single Cord Blood Transplant Supported by Co-Infusion of a Low Number of Mobilized Peripheral Blood Highly Purified CD34+ Cells from a Third Party Donor after Low Toxicity Myeloablative Conditioning. a Strategy That Makes Cord Blood Transplant Feasible for Most Patients. (An “Allostem” Study).

Manuel N. Fernandez, MD, PhD, Carmen Regidor, MD, PhD, Rafael Cabrera, MD, PhD, Elena Magro, MD, Rafael Fores, MD, Guiomar Bautista, MD, Jorge Gayoso, MD, Elena Ruiz, MD, Belen Navaro, MD, Santiago Gil, MD, Isabel Sanjuan, MD, PhD, Jose A. Garcia-Marco, MD, PhD

Blood (2004) 104 (11): 823.

https://doi.org/10.1182/blood.V104.11.823.823

Published: 2004

NARROW

Frequency, Clinical Characteristics and Outcome of Adult Patients with Acute Lymphoblastic Leukemia (ALL) and COVID-19 in Spain: Results of a Survey from Pethema and Geth Groups

Identification of Immunological Parameters Related to Relapse in Patients with Chronic Myeloid Leukemia on Treatment-Free Remission

Leukemogenesis in Seven Donor Cell Derived Myeloid Neoplasms Patients. Whole Exome Sequencing Reveals Clonal Dynamics

Real Life Long-Term Survival Analysis in Patients with Chronic Myeloid Leukemia Treated with Tkis in Spain

High Correlation Clinical Responses to 1 st Line Acute Myeloid Leukemia Treatment with an Ex Vivo Native Environment Precision Medicine Test

Safety and Efficacy of Bosutinib in Fourth Line Therapy of Chronic Myeloid Leukemia Patients

Bosutinib Apears to be Safe, with Low Cross Intolerance, in Patients Treated in 4th Line. Results of the Spanish Compassionate Use Program

Paroxysmal Nocturnal Hemoglobinuria and Thrombosis Before and After Eculizumab

Paroxysmal Nocturnal Hemoglobinuria and Cancer: High Incidence Of Cancer In a Large Series Of PNH Patients In a Single Center

Paroxysmal Nocturnal Hemoglobinuria and Magnetic Resonance Imaging

Outcomes of Chronic Myeloid Leukemia (CML) Patients Who Stopped Second Generation Tyrosine Kinase Inhibitors (2GTKIs) As Second Line Treatment. Results of the CML Spanish National Registry (RELMC)

Switching to a Second Generation TKI in Chronic Myeloid Leukemia Patients with Late Suboptimal Response with Imatinib Obtained Better Molecular Responses That the “Watch and Wait” Approach. an Experience of a Multicenter Registry in Patients Outside Clinical Trials

A Good Adherence to ELN 09 Recommendations in Chronic Myeloid Leukemia (CML) Treatment with Imatinib, Is Associated with Better Outcomes in Patients Treated Outside Clinical Trials

Use of Romiplostim to Facilitate Platelet Engraftment in Allogeneic Hematopoietic Transplantation

Analysis of Procoagulants Phospholipids in Plasma of Paroxysmal Nocturnal Hemoglobinuria Patients,Processed in Differents Preanalytic Conditions

Survival and Response Outcomes to Different Treatment Schedules in CML Patients Starting Therapy with Imatinib. Results from the CML Spanish Registry (RELMC)

Use of Third Party Ancillary Cells for Enhancement of Full Donor Chimerism and Immunomodulation in Cord Blood Transplants.

Single Unit Cord Blood Transplant Supported by Third Party Highly Purified Mobilized Hematopoietic Stem Cells: Immune Reconstitution Studies.

Post-Engraftment Infections in Adult Patients Transplanted with Single Cord Blood Units Supported by Co-Infusion of Mobilized Purified Hematopoietic Stem Cells from a Third Party Donor.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only